Allergy and Infectious Diseases Research — CFDA 93.855
$36.4 billion in federal obligations is indexed on USAspending.gov for Allergy and Infectious Diseases Research (CFDA 93.855). That total covers 13,068 assistance awards, 1,013 recipients, and a 52-state geographic count. The figure is an obligation sum from assistance listings, not cash outlays. SpendingVault republishes the CFDA row so readers can open the award table without treating the headline as a budget request or a spent-to-date cash number.
Key figures
- CFDA 93.855 (Allergy and Infectious Diseases Research) shows $36.4 billion in USAspending obligations.
- The listing covers 13,068 awards and 1,013 recipients.
- Awards are coded to 52 states in the USAspending geographic count.
- Figures are obligations from assistance awards, not outlays.
What the $36.4 billion obligation total includes
USAspending.gov records $36,365,364,946.68 in obligations under CFDA 93.855. In federal assistance accounting, an obligation is the legal commitment recorded when an award is made. It is not the same as an outlay, which is money actually drawn. A reader comparing this listing to an agency press release or an appropriations bill should keep that distinction in view: the $36.4 billion is the assistance-award obligation stock on this CFDA, not a statement of remaining unspent balances.
Allergy and Infectious Diseases Research is a high-dollar assistance listing with a large award roster. Thirteen thousand sixty-eight awards sit under the same CFDA number, so the headline is a sum of many discrete records rather than a handful of block grants. That structure matters for anyone trying to reverse-engineer a single “program budget.” The listing aggregates research assistance tagged 93.855; it does not, by itself, say how much any one laboratory, hospital, or university drew in a given month.
Awards, recipients, and how the roster is spread
The 13,068 awards map to 1,013 recipients. That is a many-awards-per-recipient pattern: on a simple average, each recipient is associated with about 13 awards and about $35.9 million in obligations. Averages hide skew. A small set of research organizations can hold a large share of dollars while hundreds of smaller recipients appear as one- or two-award rows. The USAspending extract used here reports counts, not a Lorenz curve, so concentration has to be read from the program page’s recipient table rather than from the headline.
Fifty-two states appear in the geographic count. That is a nationwide research footprint in the USAspending state field, not a claim that every county hosts a 93.855 award. State counts on assistance listings often include the District of Columbia and, depending on how the source coded the award, additional jurisdictions. The packet does not name which 52 labels are in the set; the live table is the place to see place-of-performance rows.
How CFDA 93.855 sits among assistance listings
Assistance Listing 93.855 is identified by that five-character CFDA number on every award in the extract. Searchers using a shorter institute nickname will not find a separate SpendingVault CFDA for that nickname unless the award was tagged 93.855. Procurement contracts, if any, would live under NAICS pages, not this assistance listing. This page is only the 93.855 assistance bucket.
Because the listing carries more than thirteen thousand awards, browsing by recipient or by state is usually faster than scrolling a raw award dump. The program hub lists the same obligation total, award count, recipient count, and state count used in this write-up. Cross-check those four numbers before treating a screenshot from another site as current.
Reading obligations without converting them to outlays
Obligation totals move when new awards are issued, when modifications increase or decrease a commitment, or when deobligations hit the file. Outlays move when Treasury payments post. A CFDA can show a large obligation stock while cash still sits unspent, or the reverse if payments catch up to older awards. Nothing in the packet reports outlays, so this copy does not invent a spend-down rate.
For 93.855, the practical use of the $36.4 billion figure is comparison: how large is this research listing relative to other assistance CFDA rows, and how many organizations appear as recipients? It is not a medical-effectiveness score and not a statement of scientific output.
Where to open the tables
The Allergy and Infectious Diseases Research program page holds the award-level and recipient-level views that sit behind these aggregates. The all-programs index places 93.855 next to other assistance listings by obligation size. Agency pages show awarding-agency totals that may include this CFDA among other listings; they are not a substitute for the 93.855 row itself. All three links below use the same USAspending-derived extract.
How to use the 93.855 counts without over-reading them
The four facts on Allergy and Infectious Diseases Research are a stock, not a scorecard. $36,365,364,946.68 is the obligation total USAspending.gov records for CFDA 93.855. Thirteen thousand sixty-eight is the award-record count. One thousand thirteen is the organizational-recipient count. Fifty-two is the geographic-state count. None of those numbers grades the science, names a pathogen, or says how much cash has been drawn. A reader who needs a remaining-balance figure or an outlay series has to look outside this extract.
Because 13,068 awards sit on 1,013 recipients, the listing is a many-row research file. Browsing by recipient usually beats scrolling every award action. Modifications of the same underlying project can each count as a row, which is why award count runs ahead of recipient count. The $36.4 billion headline should be paired with that structure whenever someone asks whether the listing is “one big grant” or “thousands of grants.” It is the latter, summed.
SpendingVault’s program page, all-programs index, and agencies index are the three internal routes that stay inside the packet’s link set. The program page is the overlay for 93.855. The programs index is for ranking this CFDA beside other assistance listings by obligation size. Agency pages are awarding-agency rollups that may include 93.855 among other listings; they are not a substitute for the CFDA row itself. Source for the dollars: USAspending.gov assistance awards.
Questions
- How much has CFDA 93.855 obligated on USAspending.gov?
- USAspending.gov records $36,365,364,946.68 in obligations for Allergy and Infectious Diseases Research, assistance listing 93.855. SpendingVault indexes that sum across 13,068 awards. The number is an obligation total, not an outlay or a remaining balance. Open the program page to see how the dollars split across recipients and states.
- How many awards and recipients are under allergy and infectious diseases research?
- The listing shows 13,068 awards and 1,013 recipients. That means many awards share the same CFDA tag while a little over a thousand named recipients appear in the aggregate. Counts come from the USAspending assistance extract; they are not a census of every lab that ever collaborated on a 93.855 project.
- Does the 52-state count mean every state received the same amount?
- No. Fifty-two states appear in the geographic count, which only says awards were coded to that many state labels. It does not say dollars were even. Some states will show large research recipients; others may have a handful of awards. The program table is the source for place-of-performance splits.
- Is $36.4 billion the same as money already paid out?
- No. Obligations are legal commitments on assistance awards. Outlays are payments. CFDA 93.855’s indexed total is the obligation stock from USAspending.gov. A modification, deobligation, or delayed draw can make cash paid differ from the obligation headline. This page does not report outlays.
CFDA/Assistance Listing numbers from USAspending assistance awards on SpendingVault.